Medical Device Third-party Logistics Market Size & Growth Forecast 2027–2036, By Segments (Service, Type, Device Type, Class, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Medical Device Third-party Logistics Market size was more than USD 33.37 billion in 2026 and is set to grow at a 9.54% CAGR between 2027 and 2036, reaching USD 83 billion by 2036. The industry revenue for 2027 is assessed at USD 36.07 billion.
Get more details on this report
Request Free Sample ReportMedical Device Third-party Logistics Market Intelligence Snapshot
Regional Market Dynamics
- North America held 42.69% of market revenue in 2026, benefiting from mature healthcare infrastructure, established distribution networks, and demand for specialized storage, transportation, inventory management, and regulatory support.
- Asia Pacific is expected to grow fastest as healthcare infrastructure, medical device manufacturing, and healthcare expenditure expand, increasing demand for specialized transportation, temperature-controlled storage, and supply chain management.
Segment Momentum
- Warehousing and storage account for 40.14% of the market in 2026, reflecting demand for secure facilities, inventory visibility, traceability, and reliable fulfillment to maintain medical device availability across healthcare supply chains.
- Cold chain logistics is growing fastest as certain medical devices and associated products require temperature-controlled handling. Investment in temperature monitoring, validated storage, specialized packaging, and shipment traceability supports product integrity.
Market Expansion Drivers
- Increasing demand for third-party logistics in medical devices.
- Adoption of technology-enabled tracking and cold chain solutions.
- Expansion of healthcare infrastructure in emerging markets.
Leading Market Participants
- Major companies in the medical device third-party logistics market include DHL Supply Chain (Germany), UPS Healthcare (USA), FedEx Logistics (USA), Kuehne+Nagel (Switzerland), DB Schenker (Germany), CEVA Logistics (France), Ryder System (USA), Agility Logistics (Kuwait), Nippon Express (Japan), Sinotrans (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 33.37 billion
- 2027 Estimated Market Size: USD 36.07 billion
- Projected Market Size: USD 83 billion by 2036
- Growth Forecast: 9.54% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Service (Warehousing and Storage) | Type (Non-cold Chain Logistics) | Device Type (Diagnostic Devices) | Class (Class I) | End Use (Medical Device Companies)
- Emerging Opportunity Segment: Service (Transportation) | Type (Cold Chain Logistics) | Device Type (Therapeutic Devices) | Class (Class III) | End Use (Hospitals & Clinics)
Market Growth Drivers and Industry Trends
Increasing demand for third-party logistics in medical devices
The increasing demand for third-party logistics in medical devices is driving market growth as manufacturers and healthcare providers seek specialized supply chain capabilities for the storage, transportation, and distribution of regulated medical products. Medical devices often require controlled handling, traceability, specialized packaging, and compliance with stringent quality requirements throughout the logistics process. Outsourcing these activities enables healthcare and medical device organizations to access dedicated logistics expertise while focusing internal resources on manufacturing and clinical operations. The growing complexity of healthcare supply chains is therefore encouraging greater reliance on specialized third-party logistics services.
Adoption of technology-enabled tracking and cold chain solutions
The adoption of technology-enabled tracking and cold chain solutions is strengthening the medical device logistics market by improving shipment visibility, condition monitoring, inventory control, and supply chain responsiveness. Connected tracking systems can provide real-time information on product location and handling conditions, helping logistics providers identify disruptions and maintain product integrity throughout transportation. Cold chain capabilities are particularly important for temperature-sensitive devices and associated medical products that require controlled environments. Integration of digital monitoring, automated alerts, and data-driven logistics management is improving operational reliability and supporting compliance across increasingly complex healthcare supply chains.
Expansion of healthcare infrastructure in emerging markets
The expansion of healthcare infrastructure in emerging markets is increasing demand for specialized logistics services as hospitals, clinics, diagnostic facilities, and other healthcare institutions require reliable access to medical devices and equipment. Investments in healthcare capacity are creating more geographically dispersed distribution networks, increasing the need for efficient transportation, warehousing, inventory management, and last-mile delivery capabilities. Third-party logistics providers can support these developing supply chains by offering specialized infrastructure and regulatory expertise, helping manufacturers extend distribution into markets where internal logistics networks may be less established.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing demand for third-party logistics in medical devices | 3.5% | Short term (≤ 2 yrs) | North America; Europe | Medium | Fast |
| Adoption of technology-enabled tracking and cold chain solutions | 3% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Expansion of healthcare infrastructure in emerging markets | 2.95% | Long term (5+ yrs) | Asia Pacific; Latin America | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest revenue share of 42.69% in the medical device third-party logistics market in 2026. The region’s leading position is driven by a mature healthcare infrastructure, well-developed medical device distribution networks, and strong demand for specialized logistics services that support the handling, storage, and transportation of sensitive healthcare products. Increasing complexity across medical device supply chains is encouraging manufacturers and healthcare organizations to rely on specialized logistics providers for inventory management, warehousing, transportation, and regulatory compliance. In addition, the growth of technologically advanced medical devices and the need for efficient, traceable, and reliable distribution systems are supporting continued demand for third-party logistics services throughout North America.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth in the medical device third-party logistics market, supported by expanding healthcare infrastructure, increasing medical device manufacturing, and rising healthcare expenditure across emerging economies. The development of hospitals, diagnostic facilities, and specialized healthcare networks is creating greater demand for efficient distribution and supply chain management services. Growing adoption of advanced medical equipment and the expansion of domestic and international medical device supply chains are further increasing the need for temperature-controlled storage, specialized transportation, inventory management, and regulatory support. Moreover, improving logistics infrastructure and the continued modernization of healthcare systems are expected to create significant opportunities for third-party logistics providers across Asia Pacific.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Regulated Logistics InfrastructureIn the U.S., medical device 3PL demand centers on specialized warehousing, compliant transportation, inventory visibility, and device handling requirements. Providers can differentiate through validated processes, technology-enabled traceability, and fulfillment capabilities that support manufacturers navigating complex healthcare distribution networks.
Germany 🇩🇪
Precision Distribution OperationsGermany’s medical device 3PL market emphasizes dependable distribution, regulatory compliance, and controlled handling across healthcare supply chains. Logistics providers can prioritize inventory accuracy, quality management, temperature-sensitive capabilities where required, and integrated systems that give manufacturers greater control over European fulfillment operations.
Japan 🇯🇵
Specialized Healthcare FulfillmentJapan’s medical device logistics environment favors highly reliable handling, precise inventory management, and dependable delivery to healthcare institutions and distributors. Third-party logistics providers can strengthen their proposition through localized fulfillment networks, traceability, careful product handling, and services tailored to complex device distribution requirements.
South Korea 🇰🇷
Technology-Enabled Device LogisticsSouth Korea’s medical device 3PL market is supported by demand for efficient, technology-enabled distribution and inventory control. Providers can focus on real-time shipment visibility, automated warehouse processes, regulatory documentation, and flexible fulfillment models serving manufacturers, hospitals, distributors, and specialized healthcare channels.
France 🇫🇷
Compliant Healthcare DistributionFrance requires medical device logistics solutions that combine regulatory discipline with dependable healthcare distribution. Market priorities include documented handling procedures, inventory traceability, returns management, and responsive fulfillment services that help manufacturers and distributors maintain product availability across healthcare delivery networks.
Italy 🇮🇹
Flexible Device FulfillmentItaly’s medical device 3PL demand is shaped by the need for flexible warehousing and distribution across fragmented healthcare channels. Providers can compete through regional fulfillment coverage, inventory management, reverse logistics, and compliance-focused services that reduce operational complexity for device manufacturers and distributors.
Medical Device Third-party Logistics Market Share (%), by Service, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWarehousing and Storage (Largest Segment) vs Transportation (Fastest-Growing Segment)
The warehousing and storage service segment accounts for a 40.14% share of the medical device third-party logistics market in 2026, reflecting the need for secure, organized, and compliant facilities to manage medical products across the supply chain. Medical devices often require careful inventory control, appropriate handling, traceability, and protection from damage or contamination, making specialized storage an important logistics function. Third-party providers support manufacturers and distributors through inventory visibility, order fulfillment, and storage solutions suited to different device categories. Growing outsourcing of logistics activities and the need to maintain reliable product availability across healthcare networks further reinforce demand for warehousing and storage services.
The transportation service segment is expected to grow fastest in 2026 as medical device third-party logistics supply chains increasingly require timely and dependable movement between manufacturers, distribution centers, healthcare facilities, and other end users. Efficient transportation helps maintain product availability for scheduled procedures and routine clinical operations, while specialized handling supports the movement of delicate or high-value devices. Expanding healthcare access, increasingly distributed supply networks, and demand for shipment visibility are encouraging investment in logistics capabilities. Improvements in route planning, tracking systems, and coordinated delivery services are further supporting the expansion of transportation within medical device third-party logistics.
Non-cold Chain Logistics (Largest Segment) vs Cold Chain Logistics (Fastest-Growing Segment)
The non-cold chain logistics segment holds the largest share in 2026 of the medical device third-party logistics market, reflecting the broad range of devices that can be stored and transported under standard controlled conditions without specialized temperature management. Many diagnostic, surgical, monitoring, and general medical products rely primarily on secure handling, inventory accuracy, and protection from physical damage rather than refrigerated distribution. This creates extensive demand for conventional warehousing, transportation, and fulfillment services across healthcare supply chains. Established logistics infrastructure and the comparatively broad applicability of non-cold chain processes continue to support the segment’s leading position.
The cold chain logistics segment is expected to grow fastest in 2026 as certain medical devices and associated products require temperature-controlled handling to preserve quality, performance, or stability. Increasing complexity in healthcare products and greater attention to validated storage and transportation conditions are encouraging providers to develop specialized cold chain capabilities. Temperature monitoring, shipment traceability, and controlled packaging help reduce exposure to conditions that could compromise product integrity. As healthcare distribution networks expand and requirements for sensitive products become more prominent, demand for reliable cold chain logistics is gaining importance.
Diagnostic Devices (Largest Segment) vs Therapeutic Devices (Fastest-Growing Segment)
In 2026, the diagnostic devices segment represents the largest share of the medical device third-party logistics market, supported by the extensive distribution requirements associated with equipment and products used to identify, monitor, and assess medical conditions. These devices move through complex supply chains serving hospitals, laboratories, clinics, and other healthcare providers, creating demand for dependable storage, inventory management, and delivery. Proper handling is important for protecting sensitive components and ensuring products reach facilities in usable condition. Continued use of diagnostic technologies across routine testing and clinical decision-making supports recurring logistics requirements and reinforces the segment’s leading position.
The therapeutic devices segment is expected to grow fastest in 2026 as healthcare systems expand the use of devices designed to treat, manage, or support recovery from medical conditions. These products can involve varied handling and distribution requirements, including specialized packaging, careful tracking, and reliable delivery to healthcare facilities and patients. Growth in procedural care, home-based treatment, and technology-enabled therapeutic solutions is increasing the need for coordinated logistics services. Third-party providers that can offer responsive distribution, product visibility, and handling suited to different therapeutic device categories are positioned to support this expanding demand in medical device third-party logistics.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Service | Transportation, Warehousing and Storage, Inventory Management, Packaging & Labelling, Others | Warehousing and Storage | Transportation |
| Type | Cold Chain Logistics, Non-cold Chain Logistics | Non-cold Chain Logistics | Cold Chain Logistics |
| Device Type | Diagnostic Devices, Therapeutic Devices | Diagnostic Devices | Therapeutic Devices |
| Class | Class I, Class II, Class III | Class I | Class III |
| End Use | Medical Device Companies, Hospitals & Clinics, Others | Medical Device Companies | Hospitals & Clinics |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Third-party logistics providers in the medical device sector must maintain validated, temperature-controlled cold chains and ambient monitoring to protect sensitive product integrity across global distribution channels. Rigorous regulatory compliance, serial tracking, and end-to-end auditability are paramount, requiring seamless system integration to eliminate data gaps and meet stringent healthcare mandates. Additionally, logistics partners face unique operational demands in reverse logistics, where sterile device handling and validated reprocessing require disciplined, traceable pathways. Ultimately, providers differentiate through real-time inventory visibility and synchronized platform integration that ensures uncompromised compliance and continuous product availability.
Prominent players in the medical device third-party logistics market:
- DHL Supply Chain (Germany)
- UPS Healthcare (USA)
- FedEx Logistics (USA)
- Kuehne+Nagel (Switzerland)
- DB Schenker (Germany)
- CEVA Logistics (France)
- Ryder System (USA)
- Agility Logistics (Kuwait)
- Nippon Express (Japan)
- Sinotrans (China)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| DHL Supply Chain (Germany) | |||||||
| UPS Healthcare (USA) | |||||||
| FedEx Logistics (USA) | |||||||
| Kuehne+Nagel (Switzerland) | |||||||
| DB Schenker (Germany) | |||||||
| CEVA Logistics (France) | |||||||
| Ryder System (USA) | |||||||
| Agility Logistics (Kuwait) | |||||||
| Nippon Express (Japan) | |||||||
| Sinotrans (China) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| OrthoEx | March 2025 | OrthoEx expanded its medical device distribution services to include tissue banking, enabling the secure storage and distribution of human cells, tissues, and cellular-based products to enhance healthcare logistics solutions. |
| GlobalMed Logistix | February 2024 | GlobalMed Logistix expanded its Atlanta campus in the United States, increasing its operational footprint by 200% with a 65,000-square-foot facility designed to meet rising healthcare sector demand for specialized medical device handling and third-party logistics. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Medical Device Third-party Logistics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Contract Model | Dedicated Contract Logistics, Shared-User Contract Logistics, Transaction-Based Logistics |
| Supply Chain Stage | Inbound Logistics, Manufacturing-Site Logistics, Distribution & Outbound Logistics, Reverse Logistics |
| Logistics Mode | Road Freight, Air Freight, Ocean Freight, Rail & Multimodal Transport |
Medical Device Third-party Logistics Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Device Traceability & Reverse Logistics Strategy |
|
| Healthcare Distribution Network Strategy |
|
| Logistics Resilience & Continuity Planning |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market size of the medical device third-party logistics market?
How is the medical device third-party logistics industry expected to grow over the next 10 years?
How is supply chain complexity influencing outsourcing decisions in the medical device logistics market?
Why are digital tracking and cold chain capabilities becoming strategic priorities in medical device logistics?
Why does warehousing and storage dominate medical device third-party logistics?
How is cold chain logistics creating new growth opportunities in medical device distribution?
What gives North America a competitive advantage in medical device third-party logistics?
Why is Asia Pacific becoming an important growth market for medical device logistics providers?
Who are the leading players in the medical device third-party logistics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook